View Document Preview and Link Document Date: 2015-03-05 09:54:25 Open Document File Size: 1,62 MB Share Result on Facebook
Company NewLink Pharmaceuticals / Johnson & Johnson / Merck / Novavax / / Continent Africa / / Country Germany / Switzerland / Guinea / Mali / Senegal / Kenya / United States / Canada / Nigeria / Liberia / United Kingdom / Ghana / Gabon / Sierra Leone / Cameroon / / Event FDA Phase / / IndustryTerm spontaneous reporting systems / trial protocols / preventive solutions / scaled-up manufacturing / / MedicalCondition disease / Ebola / Overall declining disease / recombinant vesicular stomatitis virus / / MedicalTreatment immunization / vaccination / / NaturalFeature Sierra Leone / / Organization National Institute of Health / World Health Organization / US CDC / European Union / European Parliament / NewLink Pharmaceuticals/Public Health Agency / / Person Roberto Bertollini / / Position MPH Chief Scientist / Representative / / Product Ad26/MVA / GSK / USA / GSK vaccine / / Technology trial protocols / 2 protocols / / SocialTag 
WHO’s response to the Ebola epidemic Dr XXXX Health Systems and Innovation